Tumor cells can increase the number of platelets in blood via thrombopoietin, IL-6 or leukemia inhibitory factor (62), and in turn, platelets facilitate tumor cell survival and escape from immune clearance mechanisms (63). Here, LIF is linked to neoplasm.